http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011148289-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011148289-A |
| titleOfInvention | METHODS OF PERSONALIZED EX VIVO MEDICAL TESTING FOR HEMATOLOGICAL NOVOGRAPHIES |
| abstract | 1. A method for analyzing cellular drug sensitivity, comprising obtaining a tissue sample from a hematologic tumor that has been extracted from a patient; dividing a tissue sample by at least 35 aliquots; combining at least 35 aliquots, each of which contains a drug composition; and measuring apoptosis in at least one cell population in each of at least 35 aliquots. 2. The method of claim 1, wherein said tissue is tissue selected from the group consisting of peripheral blood, bone marrow, lymph node, and spleen. The method according to claim 1, where the measurement is carried out within 72 hours of combining aliquots with the drug composition. The method according to claim 1, wherein the measurement is carried out within about 48 hours of combining the aliquots with the drug composition. The method according to claim 1, wherein the measurement is carried out within about 24 hours of combining the aliquots with the drug composition. The method of claim 1, wherein the number of aliquots containing the unique drug composition is at least about 96.7. The method of claim 1, wherein the sample is divided into at least 100 aliquots. The method according to claim 1, where at least two of the medicinal compositions contain the same drug in different concentrations. The method of claim 1, wherein at least one of the drug compositions comprises a plurality of drugs. The method of claim 1, wherein at least one of the drug compositions comprises a plurality of drugs that are not cytotoxic. The method according to claim 1, where at least one of the medicinal compositions contains a non-cytotoxic drug |
| priorityDate | 2009-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.